Analysts See $1.31 EPS for CVS Health (CVS), Virtus Investment Advisers Cut Tjx Cos New (TJX) Holding

June 30, 2017 - By wolcottdaily

Virtus Investment Advisers Inc decreased Tjx Cos Inc New (TJX) stake by 15.28% reported in 2016Q4 SEC filing. Virtus Investment Advisers Inc sold 17,678 shares as Tjx Cos Inc New (TJX)’s stock declined 3.78%. The Virtus Investment Advisers Inc holds 97,997 shares with $7.36 million value, down from 115,675 last quarter. Tjx Cos Inc New now has $45.92B valuation. The stock rose 0.90% or $0.64 reaching $71.72. About 300 shares traded. TJX Companies Inc (NYSE:TJX) has declined 2.02% since June 30, 2016 and is downtrending. It has underperformed by 18.72% the S&P500.

Analysts expect CVS Health Corp (NYSE:CVS) to report $1.31 EPS on August, 1.They anticipate $0.01 EPS change or 0.76% from last quarter’s $1.32 EPS. CVS’s profit would be $1.32B giving it 15.30 P/E if the $1.31 EPS is correct. After having $1.17 EPS previously, CVS Health Corp’s analysts see 11.97% EPS growth. About 200 shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 30, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Among 22 analysts covering The TJX Companies (NYSE:TJX), 20 have Buy rating, 0 Sell and 2 Hold. Therefore 91% are positive. The TJX Companies had 34 analyst reports since August 10, 2015 according to SRatingsIntel. As per Wednesday, May 17, the company rating was upgraded by Morgan Stanley. BMO Capital Markets upgraded it to “Outperform” rating and $85 target in Tuesday, February 2 report. Wedbush maintained the shares of TJX in report on Wednesday, November 16 with “Outperform” rating. The stock of TJX Companies Inc (NYSE:TJX) earned “Market Perform” rating by Telsey Advisory Group on Wednesday, November 16. Stifel Nicolaus maintained TJX Companies Inc (NYSE:TJX) on Wednesday, November 16 with “Buy” rating. UBS maintained the shares of TJX in report on Wednesday, August 19 with “Buy” rating. RBC Capital Markets maintained it with “Outperform” rating and $80 target in Wednesday, November 16 report. The stock has “Buy” rating by Deutsche Bank on Thursday, February 25. The firm has “Outperform” rating given on Thursday, February 25 by Wolfe Research. As per Wednesday, May 18, the company rating was maintained by Bernstein.

Since March 3, 2017, it had 0 insider purchases, and 3 insider sales for $2.06 million activity. Another trade for 21,180 shares valued at $1.66M was sold by MacMillan Michael. On Wednesday, May 17 the insider Sherr Richard sold $89,110. Shares for $303,211 were sold by Canestrari Kenneth on Thursday, June 1.

Investors sentiment increased to 1.02 in Q4 2016. Its up 0.07, from 0.95 in 2016Q3. It is positive, as 55 investors sold TJX shares while 372 reduced holdings. 99 funds opened positions while 335 raised stakes. 553.24 million shares or 0.41% more from 550.99 million shares in 2016Q3 were reported. Moreover, M&R Incorporated has 0.05% invested in TJX Companies Inc (NYSE:TJX) for 2,230 shares. Fiera has invested 1.94% in TJX Companies Inc (NYSE:TJX). 83,940 were reported by Cohen Lawrence B. Comerica Financial Bank invested in 230,599 shares or 0.14% of the stock. Century Inc accumulated 5.29 million shares. Athena Cap Limited Liability invested 0.29% in TJX Companies Inc (NYSE:TJX). Mesirow Investment holds 0.04% of its portfolio in TJX Companies Inc (NYSE:TJX) for 8,260 shares. Fdx Advsrs reported 28,346 shares stake. Hutchin Hill Cap Lp holds 0.06% of its portfolio in TJX Companies Inc (NYSE:TJX) for 22,000 shares. S&Co has invested 0.06% in TJX Companies Inc (NYSE:TJX). Coldstream Capital Mgmt owns 25,107 shares or 0.31% of their US portfolio. Korea Invest owns 470,583 shares. Massachusetts Financial Service Communications Ma reported 5.44M shares stake. Wafra Invest Advisory Inc holds 0.93% or 228,115 shares in its portfolio. Robecosam Ag stated it has 0.05% in TJX Companies Inc (NYSE:TJX).

Virtus Investment Advisers Inc increased Disney Walt Co (NYSE:DIS) stake by 6,637 shares to 44,380 valued at $4.63 million in 2016Q4. It also upped Time Warner Inc (NYSE:TWX) stake by 3,418 shares and now owns 23,376 shares. Caterpillar Inc Del (NYSE:CAT) was raised too.

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It turned negative, as 135 investors sold CVS Health Corp shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Atlantic Tru Group Llc has invested 0.79% in CVS Health Corp (NYSE:CVS). Sii Invs Wi reported 17,193 shares. Hall Laurie J Trustee reported 0.47% of its portfolio in CVS Health Corp (NYSE:CVS). Clarkston Ptnrs holds 2,712 shares. Westend Ltd Com holds 667,802 shares or 0% of its portfolio. Farmers Tru holds 0.17% of its portfolio in CVS Health Corp (NYSE:CVS) for 6,411 shares. Kelly Lawrence W And Assoc Ca accumulated 0.09% or 4,887 shares. Td Cap Management Limited Liability Company has 0.03% invested in CVS Health Corp (NYSE:CVS) for 1,284 shares. Finance Counselors invested in 60,098 shares or 0.25% of the stock. Nj State Employees Deferred Compensation Plan invested 0.24% of its portfolio in CVS Health Corp (NYSE:CVS). Burke & Herbert Bank Company reported 0.53% of its portfolio in CVS Health Corp (NYSE:CVS). National Bank Of Mellon Corporation holds 0.25% of its portfolio in CVS Health Corp (NYSE:CVS) for 11.07M shares. 3.06M are owned by Sumitomo Mitsui Trust Inc. Advantus Capital Mngmt holds 0.22% or 106,391 shares in its portfolio. Clal Insur Enter Limited has invested 0.03% in CVS Health Corp (NYSE:CVS).

Among 18 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. CVS Health had 28 analyst reports since July 22, 2015 according to SRatingsIntel. Morgan Stanley downgraded CVS Health Corp (NYSE:CVS) rating on Monday, June 20. Morgan Stanley has “Equal-Weight” rating and $104 target. The firm has “Hold” rating given on Wednesday, July 22 by Deutsche Bank. S&P Research maintained CVS Health Corp (NYSE:CVS) rating on Monday, November 2. S&P Research has “Strong Buy” rating and $112 target. The firm has “Buy” rating by Vetr given on Monday, August 24. UBS initiated the stock with “Buy” rating in Thursday, October 6 report. Deutsche Bank maintained the stock with “Hold” rating in Thursday, August 20 report. The stock has “Overweight” rating by JP Morgan on Monday, November 2. The company was maintained on Monday, November 2 by Oppenheimer. The stock has “Overweight” rating by Barclays Capital on Friday, December 18. The stock of CVS Health Corp (NYSE:CVS) has “Outperform” rating given on Friday, August 28 by Oppenheimer.

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The company has market cap of $80.68 billion. The Firm provides pharmacy care for the senior community through Omnicare, Inc. and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It has a 16.62 P/E ratio. It operates through three divisions: Pharmacy Services, Retail/LTC and Corporate.

Since February 1, 2017, it had 0 insider purchases, and 7 sales for $40.53 million activity. 14,104 shares were sold by Sussman Andrew, worth $1.13 million. Denton David M sold $7.71M worth of stock. Roberts Jonathan C sold $4.90 million worth of stock or 61,196 shares. 23,849 CVS Health Corp (NYSE:CVS) shares with value of $1.88 million were sold by Brennan Troyen A. The insider Boratto Eva C sold 6,029 shares worth $479,908. 76,494 shares were sold by MERLO LARRY J, worth $5.99 million on Wednesday, February 1.